Obstructive Sleep Apnea Treatment in Serious Mental Illness

NANot yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Schizoaffective DisorderSchizophreniaBipolar DisorderObstructive Sleep Apnea of Adult
Interventions
DEVICE

Automatic Positive Airway Pressure (APAP)

"If eligible, participants will be given a clinical Automatic Positive Airway Pressure (APAP) device for up to 3 months, while they are waiting for their clinical evaluation from a sleep physician. The APAP device will we will be using is the ResMed Airsense 11 Autoset. APAP is a smart positive airway pressure (PAP) device, where the pressure changes as needed to provide optimal pressure to splint the upper airway. Dr. Lee and Dr. Schmickl will oversee management of the device.~During the first month of APAP use, individuals will participate in weekly phone calls or in-person visits to ensure optimal adherence and troubleshoot any issues (improper mask fitting, discomfort, etc) that may arise."

Trial Locations (1)

92037

UCSD, La Jolla

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT05457127 - Obstructive Sleep Apnea Treatment in Serious Mental Illness | Biotech Hunter | Biotech Hunter